EdgarLookup

CVB FINANCIAL CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CVB FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.3%
Return on Assets
Net income ÷ assets
5.81x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $209.30M Feb 27, 2026
FY2025 Dec 31, 2024 $200.72M Feb 27, 2026
FY2025 Dec 31, 2023 $221.44M Feb 27, 2026
FY2024 Dec 31, 2022 $235.43M Feb 28, 2025
FY2023 Dec 31, 2021 $212.52M Feb 28, 2024
FY2020 Dec 31, 2020 $50.06M Mar 1, 2021
FY2020 Sep 30, 2020 $47.49M Mar 1, 2021
FY2020 Jun 30, 2020 $41.63M Mar 1, 2021
FY2020 Mar 31, 2020 $37.98M Mar 1, 2021
FY2020 Dec 31, 2019 $51.28M Mar 1, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $314.00M Feb 27, 2026
FY2024 Dec 31, 2024 $314.00M Feb 28, 2025
FY2023 Dec 31, 2023 $314.00M Feb 28, 2024
FY2022 Dec 31, 2022 $300.0K Feb 28, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $221.41M Feb 27, 2026
FY2025 Dec 31, 2024 $249.77M Feb 27, 2026
FY2025 Dec 31, 2023 $295.63M Feb 27, 2026
FY2024 Dec 31, 2022 $273.73M Feb 28, 2025
FY2023 Dec 31, 2021 $195.24M Feb 28, 2024
FY2022 Dec 31, 2020 $185.10M Feb 28, 2023
FY2021 Dec 31, 2019 $208.18M Mar 1, 2022
FY2020 Dec 31, 2018 $164.95M Mar 1, 2021
FY2019 Dec 31, 2017 $138.41M Mar 2, 2020
FY2018 Dec 31, 2016 $124.53M Mar 1, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.07M Feb 27, 2026
FY2025 Dec 31, 2024 $5.14M Feb 27, 2026
FY2025 Dec 31, 2023 $4.52M Feb 27, 2026
FY2024 Dec 31, 2022 $5.36M Feb 28, 2025
FY2023 Dec 31, 2021 $4.68M Feb 28, 2024
FY2022 Dec 31, 2020 $4.67M Feb 28, 2023
FY2021 Dec 31, 2019 $5.52M Mar 1, 2022
FY2020 Dec 31, 2018 $4.19M Mar 1, 2021
FY2019 Dec 31, 2017 $4.89M Mar 2, 2020
FY2018 Dec 31, 2016 $12.62M Mar 1, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.63B Feb 27, 2026
FY2025 Dec 31, 2024 $15.15B Feb 27, 2026
FY2024 Dec 31, 2023 $16.02B Feb 28, 2025
FY2023 Dec 31, 2022 $16.48B Feb 28, 2024
FY2022 Dec 31, 2021 $15.88B Feb 28, 2023
FY2021 Dec 31, 2020 $14.42B Mar 1, 2022
FY2020 Dec 31, 2019 $11.28B Mar 1, 2021
FY2019 Dec 31, 2018 $11.53B Mar 2, 2020
FY2018 Dec 31, 2017 $8.27B Mar 1, 2019
FY2017 Dec 31, 2016 $8.07B Mar 1, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.34B Feb 27, 2026
FY2025 Dec 31, 2024 $12.97B Feb 27, 2026
FY2024 Dec 31, 2023 $13.94B Feb 28, 2025
FY2023 Dec 31, 2022 $14.53B Feb 28, 2024
FY2022 Dec 31, 2021 $13.80B Feb 28, 2023
FY2021 Dec 31, 2020 $12.41B Mar 1, 2022
FY2020 Dec 31, 2019 $9.29B Mar 1, 2021
FY2019 Dec 31, 2018 $9.68B Mar 2, 2020
FY2018 Dec 31, 2017 $7.20B Mar 1, 2019
FY2017 Dec 31, 2016 $7.08B Mar 1, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.30B Feb 27, 2026
FY2025 Dec 31, 2024 $2.19B Feb 27, 2026
FY2025 Dec 31, 2023 $2.08B Feb 27, 2026
FY2025 Dec 31, 2022 $1.95B Feb 27, 2026
FY2024 Dec 31, 2021 $2.08B Feb 28, 2025
FY2023 Dec 31, 2020 $2.01B Feb 28, 2024
FY2022 Dec 31, 2019 $1.99B Feb 28, 2023
FY2021 Dec 31, 2018 $1.85B Mar 1, 2022
FY2020 Dec 31, 2017 $1.07B Mar 1, 2021
FY2019 Dec 31, 2016 $990.86M Mar 2, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $765.82M Feb 27, 2026
FY2025 Dec 31, 2024 $765.82M Feb 27, 2026
FY2025 Dec 31, 2023 $765.82M Feb 27, 2026
FY2024 Dec 31, 2022 $765.82M Feb 28, 2025
FY2023 Dec 31, 2021 $663.71M Feb 28, 2024
FY2022 Dec 31, 2020 $663.71M Feb 28, 2023
FY2021 Dec 31, 2019 $663.71M Mar 1, 2022
FY2020 Dec 31, 2018 $666.54M Mar 1, 2021
FY2019 Dec 31, 2017 $116.56M Mar 2, 2020
FY2018 Dec 31, 2016 $89.53M Mar 1, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.30B Feb 27, 2026
FY2025 Dec 31, 2024 $1.20B Feb 27, 2026
FY2024 Dec 31, 2023 $1.11B Feb 28, 2025
FY2023 Dec 31, 2022 $1.00B Feb 28, 2024
FY2022 Dec 31, 2021 $875.57M Feb 28, 2023
FY2021 Dec 31, 2020 $760.86M Mar 1, 2022
FY2020 Dec 31, 2019 $682.69M Mar 1, 2021
FY2019 Dec 31, 2018 $575.81M Mar 2, 2020
FY2018 Dec 31, 2017 $494.36M Mar 1, 2019
FY2017 Dec 31, 2016 $449.50M Mar 1, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $376.39M Feb 27, 2026
FY2025 Dec 31, 2024 $204.70M Feb 27, 2026
FY2024 Dec 31, 2023 $281.29M Feb 28, 2025
FY2023 Dec 31, 2022 $203.46M Feb 28, 2024
FY2022 Dec 31, 2021 $1.73B Feb 28, 2023
FY2021 Dec 31, 2020 $1.96B Mar 1, 2022
FY2021 Dec 31, 2019 $185.52M Mar 1, 2022
FY2021 Dec 31, 2018 $163.95M Mar 1, 2022
FY2020 Dec 31, 2017 $144.38M Mar 1, 2021
FY2019 Dec 31, 2016 $121.63M Mar 2, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $200.00M Mar 1, 2013
FY2011 Dec 31, 2011 $450.00M Feb 29, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2025 Dec 31, 2023 1 Feb 27, 2026
FY2024 Dec 31, 2022 1 Feb 28, 2025
FY2023 Dec 31, 2021 1 Feb 28, 2024
FY2020 Dec 31, 2020 0 Mar 1, 2021
FY2020 Sep 30, 2020 0 Mar 1, 2021
FY2020 Jun 30, 2020 0 Mar 1, 2021
FY2020 Mar 31, 2020 0 Mar 1, 2021
FY2020 Dec 31, 2019 0 Mar 1, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2025 Dec 31, 2023 1 Feb 27, 2026
FY2024 Dec 31, 2022 1 Feb 28, 2025
FY2023 Dec 31, 2021 1 Feb 28, 2024
FY2020 Dec 31, 2020 0 Mar 1, 2021
FY2020 Sep 30, 2020 0 Mar 1, 2021
FY2020 Jun 30, 2020 0 Mar 1, 2021
FY2020 Mar 31, 2020 0 Mar 1, 2021
FY2020 Dec 31, 2019 0 Mar 1, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 135.55M Feb 27, 2026
FY2025 Dec 31, 2024 139.69M Feb 27, 2026
FY2024 Dec 31, 2023 139.34M Feb 28, 2025
FY2023 Dec 31, 2022 139.82M Feb 28, 2024
FY2022 Dec 31, 2021 135.53M Feb 28, 2023
FY2021 Dec 31, 2020 135.60M Mar 1, 2022
FY2020 Dec 31, 2019 140.10M Mar 1, 2021
FY2019 Dec 31, 2018 140.00M Mar 2, 2020
FY2018 Dec 31, 2017 110.18M Mar 1, 2019
FY2017 Dec 31, 2016 108.25M Mar 1, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $110.99M Feb 27, 2026
FY2025 Dec 31, 2024 $111.83M Feb 27, 2026
FY2025 Dec 31, 2023 $111.69M Feb 27, 2026
FY2024 Dec 31, 2022 $104.44M Feb 28, 2025
FY2023 Dec 31, 2021 $97.73M Feb 28, 2024
FY2022 Dec 31, 2020 $98.48M Feb 28, 2023
FY2021 Dec 31, 2019 $95.35M Mar 1, 2022
FY2020 Dec 31, 2018 $65.97M Mar 1, 2021
FY2019 Dec 31, 2017 $57.05M Mar 2, 2020
FY2018 Dec 31, 2016 $51.63M Mar 1, 2019